Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 1
Submit an article Journal homepage
4,484
Views
171
CrossRef citations to date
0
Altmetric
Brief Report

The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200

Muhammad Zaeem NomanINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine - Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France;Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health (L.I.H), Luxembourg City, Luxembourg
,
Bassam JanjiLaboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health (L.I.H), Luxembourg City, Luxembourg
,
Abderemane AbdouINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine - Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France
,
Meriem HasmimINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine - Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France
,
Stéphane TerryINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine - Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France
,
Tuan Zea TanCancer Science Institute of Singapore, National University of Singapore, Singapore
,
Fathia Mami-ChouaibINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine - Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France
,
Jean Paul ThieryINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine - Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France;Yong Loo Lin School of Medicine, National University of Singapore, Singapore;CNRS UMR 7057 Matter and Complex Systems, University Paris Denis Diderot, Paris, France
&
Salem ChouaibINSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine - Univ. Paris-Sud, Université Paris-Saclay, Villejuif, FranceCorrespondence[email protected]
 show all
Article: e1263412 | Received 20 Jul 2016, Accepted 14 Nov 2016, Published online: 23 Jan 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.